BACKGROUND: A stored cord blood donation may be a valuable source of hemopoietic stem cells for allogeneic transplantation when a matched sibling donor is not available. We carried out a study to define the optimal size of a national cord blood bank for the UK. DESIGN AND METHODS: We calculated the actual numbers of possible donors and the chance of finding at least one donor for 2,000 unselected and for 722 non-North Western European patients for whom searches had been initiated as a function of three levels of HLA matching (4, 5 and 6 out of 6 alleles by HLA-A, -B low and -DRB1 high resolution HLA typing) according to various donor bank sizes. RESULTS: With a bank size of 50,000, 80% of patients will have at least one donor unit available at the 5 out of 6 HLA allele match level (median 9 donors per patient), and 98% will have at least one donor at the 4 out of 6 allele match level (median 261). Doubling the size of the bank yields at least one donor for only an additional 6% of patients at the 5 of 6 allele match level. Moreover, for non-North Western European patients a 50,000 unit bank provides a donor for 50% at the 5 allele match level, and for 96% at the 4 allele match level. CONCLUSIONS: A bank containing 50,000 units is optimal for the UK and larger banks would only marginally increase the chance of finding suitable units.
BACKGROUND: A stored cord blood donation may be a valuable source of hemopoietic stem cells for allogeneic transplantation when a matched sibling donor is not available. We carried out a study to define the optimal size of a national cord blood bank for the UK. DESIGN AND METHODS: We calculated the actual numbers of possible donors and the chance of finding at least one donor for 2,000 unselected and for 722 non-North Western European patients for whom searches had been initiated as a function of three levels of HLA matching (4, 5 and 6 out of 6 alleles by HLA-A, -B low and -DRB1 high resolution HLA typing) according to various donor bank sizes. RESULTS: With a bank size of 50,000, 80% of patients will have at least one donor unit available at the 5 out of 6 HLA allele match level (median 9 donors per patient), and 98% will have at least one donor at the 4 out of 6 allele match level (median 261). Doubling the size of the bank yields at least one donor for only an additional 6% of patients at the 5 of 6 allele match level. Moreover, for non-North Western European patients a 50,000 unit bank provides a donor for 50% at the 5 allele match level, and for 96% at the 4 allele match level. CONCLUSIONS: A bank containing 50,000 units is optimal for the UK and larger banks would only marginally increase the chance of finding suitable units.
Authors: David H Howard; David Meltzer; Craig Kollman; Martin Maiers; Brent Logan; Loren Gragert; Michelle Setterholm; Mary M Horowitz Journal: Med Decis Making Date: 2008-03-18 Impact factor: 2.583
Authors: Naynesh Kamani; Stephen Spellman; Carolyn Katovich Hurley; Juliet N Barker; Franklin O Smith; Machteld Oudshoorn; Robert Bray; Anajane Smith; Thomas M Williams; Brent Logan; Mary Eapen; Claudio Anasetti; Michelle Setterholm; Dennis L Confer Journal: Biol Blood Marrow Transplant Date: 2008-01 Impact factor: 5.742
Authors: M B A Heemskerk; S M van Walraven; J J Cornelissen; R M Y Barge; R G M Bredius; R M Egeler; J L W Tj Lie; T Révész; K Sintnicolaas; N M Wulffraat; A E Donker; P M Hoogerbrugge; J J van Rood; F H J Claas; M Oudshoorn Journal: Bone Marrow Transplant Date: 2005-04 Impact factor: 5.483
Authors: Vanderson Rocha; Myriam Labopin; Guillermo Sanz; William Arcese; Rainer Schwerdtfeger; Alberto Bosi; Niels Jacobsen; Tapani Ruutu; Marcos de Lima; Jürgen Finke; Francesco Frassoni; Eliane Gluckman Journal: N Engl J Med Date: 2004-11-25 Impact factor: 91.245
Authors: Mary J Laughlin; Mary Eapen; Pablo Rubinstein; John E Wagner; Mei-Jei Zhang; Richard E Champlin; Cladd Stevens; Juliet N Barker; Robert P Gale; Hillard M Lazarus; David I Marks; Jon J van Rood; Andromachi Scaradavou; Mary M Horowitz Journal: N Engl J Med Date: 2004-11-25 Impact factor: 91.245
Authors: Mary Eapen; Pablo Rubinstein; Mei-Jie Zhang; Cladd Stevens; Joanne Kurtzberg; Andromachi Scaradavou; Fausto R Loberiza; Richard E Champlin; John P Klein; Mary M Horowitz; John E Wagner Journal: Lancet Date: 2007-06-09 Impact factor: 79.321
Authors: Hal E Broxmeyer; Edward F Srour; Giao Hangoc; Scott Cooper; Stacie A Anderson; David M Bodine Journal: Proc Natl Acad Sci U S A Date: 2003-01-07 Impact factor: 11.205
Authors: Joanne Kurtzberg; Vinod K Prasad; Shelly L Carter; John E Wagner; Lee Ann Baxter-Lowe; Donna Wall; Neena Kapoor; Eva C Guinan; Stephen A Feig; Elizabeth L Wagner; Nancy A Kernan Journal: Blood Date: 2008-08-21 Impact factor: 22.113
Authors: E Y Song; J Y Huh; S Y Kim; T G Kim; S Oh; J H Yoon; E Y Roh; M H Park; M S Kang; S Shin Journal: Bone Marrow Transplant Date: 2014-04-28 Impact factor: 5.483